Santarus Inc. About
Santarus Inc Santarus is a specialty pharmaceutical company focused
on acquiring, developing and commercializing proprietary products to enhance the
quality of life for patients with gastrointestinal diseases and disorders.
Their current efforts are focused on the commercialization of ZEGERID™. ZEGERID
is a proprietary next generation proton pump inhibitor, or PPI. PPIs are the most
frequently prescribed drugs for the treatment of many upper gastrointestinal,
or GI, diseases and disorders. ZEGERID
-- Heartburn/GERD, Erosive esophagitis, Duodenal ulcers